Recombinant adenovirus p53 agent injection combined with radiotherapy and chemotherapy for intermediate and advanced stage nasopharyngeal carcinoma

Chinese Journal of Clinical Oncology

Volumn 36, Issue 18, 2009, Pages

  Si, Yongfeng ^a   He, Chengcheng ^a   Lan, Guiping ^a   Huang, Bo ^a   Zhang, Zheng ^a   Lu, Jinlong ^a   Zhou, Rijing ^a   Jiang, He ^a  

^a Guangxi Autonomous Region Institute of Dermatology   (China)

Author keywords

Chemotherapy; Gene therapy; Nasopharyngeal carcinoma; Radiation therapy

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; PROTEIN P53; SBN 1; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEVER; FOLLOW UP; HUMAN; NASOPHARYNX CARCINOMA; RADIATION DOSE; TREATMENT RESPONSE;

EID: 70350450805     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2009.18.004     Document Type: Article

References (10)

1. Anderson SC, Johnon DE, Harris MP, et al. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus[J]. Clin Cancer Res, 1998, 7(4): 1649-1659.
2. Staples OD, Steele RJ, Lain S. p53 as a therapeutic target[J]. Surgeon, 2008, 6(4): 240-243.
3. Sah NK, Munshi A, Nishikawa T, et al. Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity[J]. Mol Cancer Ther, 2003, 2(11): 1223-1231.
4. Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer: Mechanisms reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs[J]. Eur J Pharm Sci, 2000, 11(4): 265-283. (Pubitemid 30738405)
5. Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents[J]. Cancer Res, 1999, 59(7): 1391-1399.
6. Weinrib LM. Cisplatin Chemotherapy Plus Adenoviral p53 Gene Therapy In EBV-Positive And-Negative Nasopharyngeal Carcinoma[J]. Cancer Gene Ther, 2001, 8(5): 352-360.